Evolva Holding SA (SIX: EVE) today announces the successful completion of the first part of its R&D collaboration with L’Oréal. The parties have agreed to move into the next phase of the multi-year programme.
Under this collaboration, which started in February 2014, Evolva and L’Oréal are applying Evolva’s innovative fermentation technology to develop a yeast strain optimised for sustainable and cost-effective production of a strategically important cosmetics ingredient.
With the completion of the first work package, Fabien Cabirol, L’Oreal’s new Global Head of Biotechnologies Department, said “With this partnership L’Oréal aims to leverage on Evolva strong technological platform to develop innovative cosmetic ingredients with perceivable performance and measurable sustainability benefits. L’Oréal in-house expertise combined with Evolva flexible yeast platform opens opportunities to meet the needs and aspirations of consumers”.
Evolva CEO Neil Goldsmith said: “We are pleased to have demonstrated to L’Oréal our capabilities, and the strength and elegance of our platform”.
– Ends –